The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy
Open accessAbstract
Targeted drug delivery is a precise and effective strategy in oncotherapy that can accurately deliver drugs to tumor cells or tissues to enhance their therapeutic effect and, meanwhile, weaken their undesirable side effects on normal cells or tissues. In this research field, a large number of researchers have achieved significant breakthroughs and advances in oncotherapy. Typically, nanocarriers as a promising drug delivery strategy can effectively deliver drugs to the tumor site through enhanced permeability and retention (EPR) effect-mediated passive targeting and various types of receptor-mediated active targeting, respectively. Herein, we review recent targeted drug delivery strategies and technologies for enhancing oncotherapy. In addition, we also review two mainstream drug delivery strategies, passive and active targeting, based on various nanocarriers for enhancing tumor therapy. Meanwhile, a comparison and combination of passive and active targeting are also carried out. Furthermore, we discuss the associated challenges of passive and active targeted drug delivery strategies and the prospects for further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Doxil reduces side effects compared to free adriamycin as it accumulates less in the heart [129].”
BackgroundIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 1×
“In addition, the complement system is able to maintain immune balance in the body by regulating the immune response [108].”
BackgroundFang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Van Cutsem, E., Peeters, M., Siena, S., Humblet, Y., Hendlisz, A., Neyns, B., Canon, J.-L., Van Laethem, J.-L., Maurel, J., Richardson, G., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1620 · Cited by 1,979
Cetuximab for the Treatment of Colorectal Cancer
Jonker, D. J., O'Callaghan, C. J., Karapetis, C. S., Zalcberg, J. R., Tu, D., Au, H.-J., Berry, S. R., Krahn, M., Price, T., Simes, R. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071834 · Cited by 1,904
Model Systems, Lipid Rafts, and Cell Membranes
Simons, K., & Vaz, W. L. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.32.110601.141803 · Cited by 1,670
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Attia, M. F., Anton, N., Wallyn, J., Omran, Z., & Vandamme, T. F. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13098 · Cited by 1,085
The Structure-Activity Relationship of the Antioxidant Peptides from Natural Proteins
Zou, T.-B., He, T.-P., Li, H.-B., Tang, H.-W., & Xia, E.-Q. (2016) · Molecules · doi:10.3390/molecules21010072 · Cited by 879
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837 · cited 1×
“Intravenously injected PEGylated nanoparticles (e.g., PEGylated liposomes and micelles) have a long blood circulation [32,33].”
BackgroundMonoclonal Antibodies in Cancer Therapy
Zahavi, D., & Weiner, L. (2020) · Antibodies · doi:10.3390/antib9030034 · Cited by 831
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Shen, Z., Song, J., Yung, B. C., Zhou, Z., Wu, A., & Chen, X. (2018) · Advanced Materials · doi:10.1002/adma.201704007 · Cited by 740
Mechanical properties of nanoparticles: basics and applications
Guo, D., Xie, G., & Luo, J. (2014) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/47/1/013001 · Cited by 723
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Biomedical Applications of Zinc Oxide Nanomaterials
Zhang, Y., Nayak, T., Hong, H., & Cai, W. (2013) · Current Molecular Medicine · doi:10.2174/1566524013666131111130058 · Cited by 651
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
ZnO Nanoparticles Applied to Bioimaging and Drug Delivery
Xiong, H. (2013) · Advanced Materials · doi:10.1002/adma.201301732 · Cited by 561
The role of the complement system in cancer
Afshar-Kharghan, V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90962 · Cited by 554
Nanoparticle-based drug delivery systems for cancer therapy
Dang, Y., & Guan, J. (2020) · Smart Materials in Medicine · doi:10.1016/j.smaim.2020.04.001 · Cited by 553
Romero-Garcia, S., Moreno-Altamirano, M. M. B., Prado-Garcia, H., & Sánchez-García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 506
Cellular Uptake of Elastic Nanoparticles
Yi, X., Shi, X., & Gao, H. (2011) · Physical Review Letters · doi:10.1103/physrevlett.107.098101 · Cited by 455
Folate-targeted therapies for cancer
Xia, W., & Low, P. S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100509v · Cited by 448
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection
Srinivasan, S., Guha, M., Kashina, A., & Avadhani, N. G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.004 · Cited by 436
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature
BAZAK, R., HOURI, M., ACHY, S. E., HUSSEIN, W., & REFAAT, T. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.356 · Cited by 435
Zuckerman, J. E., Gritli, I., Tolcher, A., Heidel, J. D., Lim, D., Morgan, R., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 427
In vivo degeneration and the fate of inorganic nanoparticles
Feliu, N., Docter, D., Heine, M., del Pino, P., Ashraf, S., Kolosnjaj-Tabi, J., Macchiarini, P., Nielsen, P., Alloyeau, D., Gazeau, F., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00699f · Cited by 423
Fishelson, Z. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00112-3 · Cited by 400
Impact of particle elasticity on particle-based drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.007 · Cited by 385
Complement — tapping into new sites and effector systems
Kolev, M., Friec, G. L., & Kemper, C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3761 · Cited by 349
Phage display screening of therapeutic peptide for cancer targeting and therapy
Saw, P. E., & Song, E.-W. (2019) · Protein & Cell · doi:10.1007/s13238-019-0639-7 · Cited by 279
The Structural Role of Cholesterol in Cell Membranes: From Condensed Bilayers to Lipid Rafts
Krause, M. R., & Regen, S. L. (2014) · Accounts of Chemical Research · doi:10.1021/ar500260t · Cited by 269
Targeted delivery to the nucleus☆
POUTON, C., WAGSTAFF, K., ROTH, D., MOSELEY, G., & JANS, D. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.010 · Cited by 246
Liposome-like nanostructures for drug delivery
Gao, W., Hu, C.-M. J., Fang, R. H., & Zhang, L. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21238f · Cited by 244
Recent advances in active targeting of nanomaterials for anticancer drug delivery
Dutta, B., Barick, K. C., & Hassan, P. A. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102509 · Cited by 232
Targeting cancer cells with nucleic acid aptamers
Cerchia, L., & de Franciscis, V. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.07.005 · Cited by 218
Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy
Ren, H., He, Y., Liang, J., Cheng, Z., Zhang, M., Zhu, Y., Hong, C., Qin, J., Xu, X., & Wang, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b22693 · Cited by 206
Greiner, J., Schmitt, M., Li, L., Giannopoulos, K., Bosch, K., Schmitt, A., Dohner, K., Schlenk, R. F., Pollack, J. R., Dohner, H., et al. (2006) · Blood · doi:10.1182/blood-2006-01-023127 · Cited by 205
Liu, S., Pan, J., Liu, J., Ma, Y., Qiu, F., Mei, L., Zeng, X., & Pan, G. (2018) · Small · doi:10.1002/smll.201703968 · Cited by 200
Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery
Jiang, L., Zhou, S., Zhang, X., Li, C., Ji, S., Mao, H., & Jiang, X. (2021) · Nature Communications · doi:10.1038/s41467-021-22594-2 · Cited by 191
Understanding the Effects of Nanocapsular Mechanical Property on Passive and Active Tumor Targeting
Hui, Y., Wibowo, D., Liu, Y., Ran, R., Wang, H.-F., Seth, A., Middelberg, A. P. J., & Zhao, C.-X. (2018) · ACS Nano · doi:10.1021/acsnano.8b00242 · Cited by 186
Ji, T., Zhao, Y., Ding, Y., & Nie, G. (2013) · Advanced Materials · doi:10.1002/adma.201300299 · Cited by 183
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
Scodeller, P., Simón-Gracia, L., Kopanchuk, S., Tobi, A., Kilk, K., Säälik, P., Kurm, K., Squadrito, M. L., Kotamraju, V. R., Rinken, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14709-x · Cited by 179
Kaminskas, L. M., McLeod, V. M., Kelly, B. D., Sberna, G., Boyd, B. J., Williamson, M., Owen, D. J., & Porter, C. J. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.013 · Cited by 176
Photocatalyzing CO2 to CO for Enhanced Cancer Therapy
Zheng, D., Li, B., Li, C., Xu, L., Fan, J., Lei, Q., & Zhang, X. (2017) · Advanced Materials · doi:10.1002/adma.201703822 · Cited by 175
RNA aptamers targeting cancer stem cell marker CD133
Shigdar, S., Qiao, L., Zhou, S.-F., Xiang, D., Wang, T., Li, Y., Lim, L. Y., Kong, L., Li, L., & Duan, W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.032 · Cited by 174
Self-citationNanocarriers based novel and effective drug delivery system
Khizar, S., Alrushaid, N., Alam Khan, F., Zine, N., Jaffrezic-Renault, N., Errachid, A., & Elaissari, A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122570 · Cited by 171
Nanocarriers for targeted drug delivery
Shah, A., Aftab, S., Nisar, J., Ashiq, M. N., & Iftikhar, F. J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102426 · Cited by 161
Small Molecules for Active Targeting in Cancer
Kue, C. S., Kamkaew, A., Burgess, K., Kiew, L. V., Chung, L. Y., & Lee, H. B. (2016) · Medicinal Research Reviews · doi:10.1002/med.21387 · Cited by 159
Glasgow, M. D. K., & Chougule, M. B. (2015) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2145 · Cited by 145
Role of the complement system in the tumor microenvironment
Zhang, R., Liu, Q., Li, T., Liao, Q., & Zhao, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1027-3 · Cited by 142
Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
Gilson, P., Merlin, J., & Harlé, A. (2022) · Cancers · doi:10.3390/cancers14061384 · Cited by 140
Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy
Zhang, C., Wu, W. H., Li, R., Qiu, W., Zhuang, Z., Cheng, S., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804492 · Cited by 137
Altered metabolism and mitochondrial genome in prostate cancer
Dakubo, G. D., Parr, R. L., Costello, L. C., FRANKLIN, R. B., & Thayer, R. E. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027664 · Cited by 135
Lipid-enveloped hybrid nanoparticles for drug delivery
Tan, S., Li, X., Guo, Y., & Zhang, Z. (2012) · Nanoscale · doi:10.1039/c2nr32880a · Cited by 134
Oxide and hybrid nanostructures for therapeutic applications
Chandra, S., Barick, K. C., & Bahadur, D. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.003 · Cited by 132
Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.094 · Cited by 115
Abumanhal-Masarweh, H., da Silva, D., Poley, M., Zinger, A., Goldman, E., Krinsky, N., Kleiner, R., Shenbach, G., Schroeder, J. E., Shklover, J., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.025 · Cited by 115
Adaptive immunity in the liver
Shuai, Z., Leung, M. W., He, X.-S., Zhang, W., Yang, G., Leung, P. S. C., & Gershwin, M. E. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.4 · Cited by 113
Targeting Costimulatory Molecules to Improve Antitumor Immunity
Capece, D., Verzella, D., Fischietti, M., Zazzeroni, F., & Alesse, E. (2012) · BioMed Research International · doi:10.1155/2012/926321 · Cited by 109
A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy
Li, S., Liu, L., Jia, H.-Z., Qiu, W., Rong, L., Cheng, H. B., & Zhang, X. (2014) · Chemical Communications · doi:10.1039/c4cc05008h · Cited by 108
Kojima, C., Regino, C. A. S., Umeda, Y., Kobayashi, H., & Kono, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.09.015 · Cited by 108
Surface Functionalization of ZnO Nanotetrapods with Photoactive and Electroactive Organic Monolayers
Liu, D., Wu, W. H., Qiu, Y., Yang, S., Xiao, S., Wang, Q., Ding, L., & Wang, J. (2008) · Langmuir · doi:10.1021/la800074f · Cited by 105
Self-citationAutophagy, the innate immune response and cancer
Gerada, C., & Ryan, K. M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12774 · Cited by 105
The Role of Particle Geometry and Mechanics in the Biological Domain
Best, J. P., Yan, Y., & Caruso, F. (2011) · Advanced Healthcare Materials · doi:10.1002/adhm.201100012 · Cited by 104
Praharaj, P. P., Naik, P. P., Panigrahi, D. P., Bhol, C. S., Mahapatra, K. K., Patra, S., Sethi, G., & Bhutia, S. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2990-x · Cited by 104
Liu, J. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b00493 · Cited by 103
Nanocarrier mediated combination drug delivery for chemotherapy – A review
Pushpalatha, R., Selvamuthukumar, S., & Kilimozhi, D. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.04.019 · Cited by 103
The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment
Haque, M., Shakil, M. S., & Mahmud, K. M. (2023) · Cancers · doi:10.3390/cancers15061892 · Cited by 102
Mitochondrial Dysfunction at the Center of Cancer Therapy
Chiu, H. Y., Tay, E. X. Y., Ong, D. S. T., & Taneja, R. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7898 · Cited by 95
Red Fluorescent Zinc Oxide Nanoparticle: A Novel Platform for Cancer Targeting
Hong, H., Wang, F., Zhang, Y., Graves, S. A., Eddine, S. B. Z., Yang, Y., Theuer, C. P., Nickles, R. J., Wang, X., & Cai, W. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508440j · Cited by 92
Actively targeted nanocarriers for drug delivery to cancer cells
Biffi, S., Voltan, R., Bortot, B., Zauli, G., & Secchiero, P. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1604679 · Cited by 90
Chain-Length- and Saturation-Tuned Mechanics of Fluid Nanovesicles Direct Tumor Delivery
Dai, Z., Yu, M., Yi, X., Wu, Z., Tian, F., Miao, Y., Song, W., He, S., Ahmad, E., Guo, S., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01181 · Cited by 90
Self-citationImmunology and immunotherapy of neuroblastoma
Seeger, R. C. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.012 · Cited by 86
Multifunctional peptides for tumor therapy
Li, K., Liu, C., & Zhang, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.009 · Cited by 77
Hamaguchi, T., Matsumura, Y., Nakanishi, Y., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Niki, H., Hosokawa, S., Tagawa, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02495.x · Cited by 74
Nanotechnology in Targeted Drug Delivery
Stefano, A. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098194 · Cited by 74
Gallardo, M. E., Moreno‐Loshuertos, R., López‐Menéndez, C., Casqueiro, M., Silva, J., Bonilla, F., de Córdoba, S. R., & Enríquez, J. A. (2006) · Human Mutation · doi:10.1002/humu.20338 · Cited by 71
How to unleash mitochondrial apoptotic blockades to kill cancers?
Deng, J. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.08.005 · Cited by 69
Duan, H., Liu, C., Hou, Y., Liu, Y., Zhang, Z., Zhao, H., Xin, X., Liu, W., Zhang, X., Chen, L., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c23166 · Cited by 64
Tomalia, D. A., Nixon, L. S., & Hedstrand, D. M. (2020) · Biomolecules · doi:10.3390/biom10040642 · Cited by 60
Chawla, S. P., Bruckner, H. W., Morse, M. A., Assudani, N., Hall, F. L., & Gordon, E. M. (2018) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2018.12.005 · Cited by 60
Zhou, H., Lu, X., Du, C., Zhou, Z., Feng, J., Liang, Z., Xu, Y., Qiu, X., & Shen, Z. (2022) · Small · doi:10.1002/smll.202202705 · Cited by 59
Fan, Z., Jiang, B., Zhu, Q., Xiang, S., Tu, L., Yang, Y., Zhao, Q., Huang, D., Han, J., Su, G., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c00970 · Cited by 57
Self-citationMagnetosome-inspired synthesis of soft ferrimagnetic nanoparticles for magnetic tumor targeting
Ma, K., Xu, S., Tao, T., Qian, J., Cui, Q., Rehman, S. U., Zhu, X., Chen, R., Zhao, H., Wang, C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211228119 · Cited by 57
Takechi‐Haraya, Y., Goda, Y., & Sakai‐Kato, K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00051 · Cited by 56
Qu, X., Qiu, P., Zhu, Y., Yang, M., & Mao, C. (2017) · NPG Asia Materials · doi:10.1038/am.2017.196 · Cited by 54
Electronic Nose Based on Multipatterns of ZnO Nanorods on a Quartz Resonator with Remote Electrodes
Ko, W., Jung, N., Lee, M., Yun, M., & Jeon, S. (2013) · ACS Nano · doi:10.1021/nn4027245 · Cited by 50
Perez-Penco, M., Weis-Banke, S. E., Schina, A., Siersbæk, M. S., Hübbe, M. L., Jørgensen, M. A., Lecoq, I., de la Torre, L. L., Bendtsen, S. K., Martinenaite, E., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005491 · Cited by 50
Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells
Chen, Z., Zeng, Z., Wan, Q., Liu, X., Qi, J., & Zu, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121259 · Cited by 47
Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
Li, S., & Liu, Y. (2013) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s46199 · Cited by 46
Li, S., Wang, F., Li, X., Chen, J., Zhang, X., Wang, Y., & Liu, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03160 · Cited by 42
Fan, Z., Wang, Y., Xiang, S., Zuo, W., Huang, D., Jiang, B., Sun, H., Yin, W., Xie, L., & Hou, Z. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00049c · Cited by 37
Self-citationLi, S., Gray, B. P., McGuire, M. J., & Brown, K. C. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.046 · Cited by 31
Erratum: Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2965 · Cited by 31
Aptamers in immunological research
Nezlin, R. S. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.001 · Cited by 28
The origins of cancer cell dormancy
Morales-Valencia, J., & David, G. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101914 · Cited by 25
Michaud, D. S., Houseman, E. A., Marsit, C. J., Nelson, H. H., Wiencke, J. K., & Kelsey, K. T. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0681 · Cited by 23
Zhu, H., Wu, E., Pan, Z., Zhang, C., Zhang, Y., Liao, Q., Wang, Y., Sun, Y., Ye, M., & Wu, W. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04084 · Cited by 22
Concurrent impairment of nucleus and mitochondria for synergistic inhibition of cancer metastasis
Yang, J., Li, Q., Zhou, M., Li, X., Huang, Y., Yang, N., & Zhou, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121077 · Cited by 20
Biotinylation of Cell Surface Proteins
Huang, G. N. (2012) · BIO-PROTOCOL · doi:10.21769/bioprotoc.170 · Cited by 18
Dmitrieva, M., Voitova, A. A., Dymova, M. A., Richter, V. A., & Kuligina, E. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010314 · Cited by 17
Tang, H., Zhang, Z., Zhu, M. J., Xie, Y., Lv, Z., Liu, R., Shen, Y., & Pei, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030988 · Cited by 17
Recent Advances in Aptamers Targeting Immune System
Hu, P.-P. (2016) · Inflammation · doi:10.1007/s10753-016-0437-9 · Cited by 16
Roex, M. C. J., Hageman, L., Veld, S. A. J., van Egmond, E. H. M., Hoogstraten, C., Stemberger, C., Germeroth, L., Einsele, H., Falkenburg, J. H. F., & Jedema, I. (2020) · Blood · doi:10.1182/blood.2019004443 · Cited by 16
Fan, Z., Shi, D., Zuo, W., Feng, J., Ge, D., Su, G., Yang, L., & Hou, Z. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c22350 · Cited by 12
Self-citationde la Granja, P. P., Alejos, A. D., Serrano, J. A. C., et al. (2022) · Archaeological and Anthropological Sciences · doi:10.1007/s12520-022-01652-w · Cited by 3
Development of a modularized aptamer targeting the nuclear T-cell suppressor PAC1
Hu, Z., Jiang, Z., Yang, Z., Liu, L., Zhu, Z., Jin, Y., & Yin, Y. (2023) · The Analyst · doi:10.1039/d3an00011g · Cited by 3
Cited by
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Mechanistic study of cancer drug delivery: Current techniques, limitations, and future prospects
Imtiaz, S., Ferdous, U. T., Nizela, A., Hasan, A., Shakoor, A., Zia, A. W., & Uddin, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117535 · Cited by 119
Metadata
- Authors
- Li, J., Wang, Q., Xia, G., Adilijiang, N., Li, Y., Hou, Z., Fan, Z., & Li, J.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2023-08-29
- Volume
- 15
- Issue
- 9
- Pages
- 2233
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W4386255758
- Cited by
- 278
- References
- 122
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.